Taysha Gene Therapies, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 61.47 | -100% | -4.34 | -100% |
| P/S |
|
12.7 | 33.58 | -62.18% |
|
|
| P/BV |
|
2.62 | 4.79 | -45.35% |
|
|
| P/FCF |
|
-1.54 | 60.06 | -102.56% |
|
|
| Ev/Ebitda |
|
-1.61 | -17.26 | -90.65% |
|
|
| Ev/S |
|
7.31 | 22.49 | -67.49% |
|
|
| Ev/FCF |
|
-1.41 | 67.63 | -102.08% |
|
|
| E/P |
|
-0.9012 | 0.0168 | -5450.87% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-453.06 | 4.5 | -10176.09% | -2354.97 | -80.76% |
| ROE |
|
-148.88 | 9.39 | -1685.29% |
|
|
| ROA |
|
-41.79 | 0.1519 | -27604.42% |
|
|
| ROIC |
|
-95.26 | 7.63 | -1347.78% |
|
|
| ROS |
|
-722.06 | -25.64 | 2716.07% |
|
|
| ROCE |
|
-95.25 | 15.19 | -727.19% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.6022 | -3.68 | -83.63% | -0.505 | +19.25% |
| Nеt Debt/Ebitda |
|
1.19 | -4.07 | -129.26% |
|
|
| Debt/Ratio |
|
0.1579 | 0.199 | -20.67% |
|
|
| Debt/Equity |
|
0.4373 | 1.67 | -73.74% |
|
|
| Debt/Net Income |
|
-0.3778 | 10.34 | -103.65% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5399 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2331 | -100% |
|
|
| Average dividend growth |
|
0 | 1.07 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4916 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.32 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5399 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
517.55 | 76.2 | 579.2% | ||
| Growth impulse Ebitda in 5 years |
|
9463.36 | 44.75 | 21047.17% | ||
| Growth impulse Net Income in 5 years |
|
10042.36 | -15.36 | -65479.95% | ||
| Growth impulse FCF in 5 years |
|
-59645.93 | -9.39 | 635106.92% | ||
| Growth impulse EPS in 5 years |
|
3091.93 | -84.03 | -3779.55% |
IP Score
4.45/10
